Thiazide-like diuretic — same NCC blockade as HCTZ but works synergistically with loop diuretics in diuretic-resistant heart failure. Powerful natriuresis when sequentially blocking distal tubule downstream of loop-treated proximal segments.
Half-Life & Elimination Curve (PO: 14h)
Plasma (PO)t½ Decay (14h)
0×t½0h100%(22.3 µg/L)
1×t½14h50%(11.2 µg/L)
2×t½28h25%(5.58 µg/L)
3×t½42h12.5%(2.79 µg/L)
4×t½56h6.3%(1.39 µg/L)
5×t½70h3.1%(0.697 µg/L)
Elimination t½14h (PO)
Rate Constant (ke)0.0495 h⁻¹
Time to Peak (Tmax)5.13h
Est. Peak (Cmax)22.3 µg/L
Clearance (CL)5.59 L/h
97% Washout (5×t½)70h
Dosing Guidelines
Oral (PO): Typical 5 mg (Range: 2.5–20 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 65% · Volume of Distribution (Vd): 113 L · Absorption (ka): 0.5 h⁻¹ (t½ka ≈ 1.39h) [PMID 29145890]